Skip Navigation LinksHome > March 2014 - Volume 36 - Issue 2 > Chitosan-based Dressing for the Treatment of External/Access...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e31828ac8b6
Original Articles

Chitosan-based Dressing for the Treatment of External/Accessible Bleedings in Children With Bleeding Tendency

Misgav, Mudi MD; Kenet, Gili MD; Martinowitz, Uriel MD

Collapse Box

Abstract

Introduction:

Bleeding episodes in patients with congenital or acquired bleeding disorders are usually managed with factor concentrates or blood products. However, external and accessible bleeds may effectively be managed with topical hemostasis.

Materials and Methods:

After the application of the Hemcon, a Food and Drug Administration-approved chitosan-based hemostatic dressing was used as the “last resort” to successfully control external bleeds in 2 patients with severe bleeding disorders. We describe a single-center experience with this dressing, including its use in pediatric patients as the first mode of therapy.

Results:

A total of 5 patients (median age 2 y) with severe bleeding disorders were treated with topical chitosan-based dressing for a total of 6 bleeding episodes. The dressing was used either after the failure of extensive systemic therapy or as the first choice of treatment. In 4 of the 6 episodes, bleeding ceased immediately alleviating the need for systemic therapy. There was no rebleeding after the removal of the dressing and no adverse events or local skin reactions were recorded.

Conclusion:

Hemostatic dressings, such as the chitosan, should be encouraged for the treatment of external/accessible bleeds, especially among the pediatric patients with bleeding tendency.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.